Hypophosphatemia: an evidence-based approach to its clinical consequences and management
- 1 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Nephrology
- Vol. 2 (3), 136-148
- https://doi.org/10.1038/ncpneph0124
Abstract
Optimal cellular function is dependent on maintenance of a normal serum phosphorus concentration. Serum phosphorus concentration is affected by several determinants, the most important of which is regulation of phosphorus reabsorption by the kidney. The majority of this reabsorption (80%) occurs in the proximal tubule and is mediated by an isoform of the sodium-phosphate cotransporter (NaPi-II). Parathyroid hormone, via a variety of intracellular signaling cascades leading to NaPi-IIa internalization and downregulation, is the main regulator of renal phosphate reabsorption. Shift of phosphorus from extracellular to intracellular compartments, decreased gastrointestinal absorption, and increased urinary losses, are the primary mechanisms of hypophosphatemia, which affects approximately 2% of hospitalized patients. Hypophosphatemia has been implicated as a cause of rhabdomyolysis, respiratory failure, hemolysis and left ventricular dysfunction. With the exception of ventilated patients, there is little evidence that moderate hypophosphatemia has significant clinical consequences in humans, and aggressive intravenous phosphate replacement is unnecessary. By contrast, patients with severe hypophosphatemia should be treated. Intravenous repletion may be considered, especially for patients who have clinical sequelae of hypophosphatemia.Keywords
This publication has 87 references indexed in Scilit:
- Recent Advances in Renal Phosphate TransportTherapeutic Apheresis and Dialysis, 2005
- Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1αOHase-deficient miceAmerican Journal of Physiology-Cell Physiology, 2005
- Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporterKidney International, 2004
- Regulation of intestinal phosphate cotransporter NaPi IIb by ubiquitin ligase Nedd4–2 and by serum- and glucocorticoid-dependent kinase 1American Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Intestinal Na-Picotransporter adaptation to dietary Picontent in vitamin D receptor null miceAmerican Journal of Physiology-Renal Physiology, 2004
- Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogenAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- The sodium phosphate cotransporter family SLC34Pflügers Archiv - European Journal of Physiology, 2003
- Regulation of the human sodium-phosphate cotransporter NaPi-IIb gene promoter by epidermal growth factorAmerican Journal of Physiology-Cell Physiology, 2001
- Proximal Tubular Phosphate Reabsorption: Molecular MechanismsPhysiological Reviews, 2000
- Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.JCI Insight, 1987